| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acknowledgement to Reviewers
|
|
|
2019
|
75 |
6 |
p. e186-e189
|
artikel
|
| 2 |
A Comprehensive Review of Overactive Bladder Pathophysiology: On the Way to Tailored Treatment
|
Peyronnet, Benoit
|
|
2019
|
75 |
6 |
p. 988-1000
|
artikel
|
| 3 |
Are Biomarker-driven Inclusion and Symptom Control Endpoints the Future of Phase 3 Trials in Metastatic Castration-resistant Prostate Cancer? Lessons from COMET-2
|
Østergren, Peter B.
|
|
2019
|
75 |
6 |
p. 938-939
|
artikel
|
| 4 |
askMUSIC: Leveraging a Clinical Registry to Develop a New Machine Learning Model to Inform Patients of Prostate Cancer Treatments Chosen by Similar Men
|
Auffenberg, Gregory B.
|
|
2019
|
75 |
6 |
p. 901-907
|
artikel
|
| 5 |
Cabozantinib Versus Mitoxantrone-prednisone in Symptomatic Metastatic Castration-resistant Prostate Cancer: A Randomized Phase 3 Trial with a Primary Pain Endpoint
|
Basch, Ethan M.
|
|
2019
|
75 |
6 |
p. 929-937
|
artikel
|
| 6 |
Congress Calendar
|
|
|
2019
|
75 |
6 |
p. e181-e185
|
artikel
|
| 7 |
Contents
|
|
|
2019
|
75 |
6 |
p. iv, vi, vii, viii, ix, x
|
artikel
|
| 8 |
Cost-effectiveness Analysis of Active Surveillance Strategies for Men with Low-risk Prostate Cancer
|
Sathianathen, Niranjan J.
|
|
2019
|
75 |
6 |
p. 910-917
|
artikel
|
| 9 |
Could Differences in Treatment Between Trial Arms Explain the Reduction in Prostate Cancer Mortality in the European Randomized Study of Screening for Prostate Cancer?
|
Carlsson, Sigrid V.
|
|
2019
|
75 |
6 |
p. 1015-1022
|
artikel
|
| 10 |
Editorial Board
|
|
|
2019
|
75 |
6 |
p. i-ii
|
artikel
|
| 11 |
Effective Technology-based Behaviour Change Interventions in Prostate Cancer Supportive Care: Are We There Yet?
|
Short, Camille E.
|
|
2019
|
75 |
6 |
p. 959-960
|
artikel
|
| 12 |
External Validation of the European Association of Urology Biochemical Recurrence Risk Groups to Predict Metastasis and Mortality After Radical Prostatectomy in a European Cohort
|
Tilki, Derya
|
|
2019
|
75 |
6 |
p. 896-900
|
artikel
|
| 13 |
Feasibility, Acceptability, and Behavioral Outcomes from a Technology-enhanced Behavioral Change Intervention (Prostate 8): A Pilot Randomized Controlled Trial in Men with Prostate Cancer
|
Kenfield, Stacey A.
|
|
2019
|
75 |
6 |
p. 950-958
|
artikel
|
| 14 |
Hard Problems Need “Soft” Science: Integrating Quality of Life into Treatment Decision Making
|
Morgans, Alicia K.
|
|
2019
|
75 |
6 |
p. 948-949
|
artikel
|
| 15 |
Health-related Quality of Life for Abiraterone Plus Prednisone Versus Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer: Results from a Phase II Randomized Trial
|
Khalaf, Daniel J.
|
|
2019
|
75 |
6 |
p. 940-947
|
artikel
|
| 16 |
Higher Risk of Fragility Fractures in Prostate Cancer Patients Treated with Combined Radium-223 and Abiraterone: Prednisone May Be the Culprit
|
Dalla Volta, Alberto
|
|
2019
|
75 |
6 |
p. 894-895
|
artikel
|
| 17 |
Lifelong Congenital Urology: The Challenges for Patients and Surgeons
|
Wood, Dan
|
|
2019
|
75 |
6 |
p. 1001-1007
|
artikel
|
| 18 |
Multiparametric Magnetic Resonance Imaging Before Prostate Biopsy: A Chain is Only as Strong as its Weakest Link
|
Rouvière, Olivier
|
|
2019
|
75 |
6 |
p. 889-890
|
artikel
|
| 19 |
Optimizing Prostate Cancer Surveillance: Using Data-driven Models for Informed Decision-making
|
Denton, Brian T.
|
|
2019
|
75 |
6 |
p. 918-919
|
artikel
|
| 20 |
Patient Decision-making: Where Are We Going?
|
Albertsen, Peter C.
|
|
2019
|
75 |
6 |
p. 908-909
|
artikel
|
| 21 |
Patterns of Knowledge Acquisition Among Men Undergoing Radical Prostatectomy
|
Fode, Mikkel
|
|
2019
|
75 |
6 |
p. 1040-1041
|
artikel
|
| 22 |
Personalised Medicine for Advanced Urothelial Cancer: What is the Right Way to Identify the Right Patient for the Right Treatment?
|
Crabb, Simon J.
|
|
2019
|
75 |
6 |
p. 965-966
|
artikel
|
| 23 |
Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review
|
Van den Broeck, Thomas
|
|
2019
|
75 |
6 |
p. 967-987
|
artikel
|
| 24 |
Prostate Cancer Genomic-risk Differences Between African-American and White Men Across Gleason Scores
|
Mahal, Brandon A.
|
|
2019
|
75 |
6 |
p. 1038-1040
|
artikel
|
| 25 |
Prostate-specific Membrane Antigen Across the Spectrum of Prostate Cancer: Detection, Surgery, and Theranostics
|
Murphy, Declan G.
|
|
2019
|
75 |
6 |
p. 927-928
|
artikel
|
| 26 |
Re: Alberto Briganti, Nicola Fossati, James W.F. Catto, et al. Active Surveillance for Low-risk Prostate Cancer: The European Association of Urology Position in 2018. Eur Urol 2018;74:357–68
|
Wei, Yongbao
|
|
2019
|
75 |
6 |
p. e155-e156
|
artikel
|
| 27 |
Re: Bladder Preservation with Twice-a-day Radiation plus Fluorouracil/Cisplatin or Once Daily Radiation plus Gemcitabine for Muscle-invasive Bladder Cancer: NRG/RTOG 0712—A Randomized Phase II Trial
|
Witjes, J. Alfred
|
|
2019
|
75 |
6 |
p. 1033-1034
|
artikel
|
| 28 |
Re: Evaluation of Cancer Specific Mortality with Surgery versus Radiation as Primary Therapy for Localized High Grade Prostate Cancer in Men Younger than 60 Years
|
Karnes, R. Jeffrey
|
|
2019
|
75 |
6 |
p. 1035-1036
|
artikel
|
| 29 |
Re: Financial Conflicts of Interest Among Authors of Urology Clinical Practice Guidelines
|
Dahm, Philipp
|
|
2019
|
75 |
6 |
p. 1032-1033
|
artikel
|
| 30 |
Re: F. Johannes P. van Valenberg, Andrew M. Hiar, Ellen Wallace, et al. Prospective Validation of an mRNA-based Urine Test for Surveillance of Patients with Bladder Cancer. Eur Urol 2019;75:853–60
|
Pichler, Renate
|
|
2019
|
75 |
6 |
p. e175-e176
|
artikel
|
| 31 |
Re: Guido Giusti, Silvia Proietti, Moises E. Rodríguez-Socarrás, et al. Simultaneous Bilateral Endoscopic Surgery (SBES) for Patients with Bilateral Upper Tract Urolithiasis: Technique and Outcomes. Eur Urol 2018;74:810–5
|
Boeri, Luca
|
|
2019
|
75 |
6 |
p. e171-e172
|
artikel
|
| 32 |
Re: Impact of Immune and Stromal Infiltration on Outcomes Following Bladder-sparing Trimodality Therapy for Muscle-invasive Bladder Cancer
|
Narayan, Vikram M.
|
|
2019
|
75 |
6 |
p. 1034-1035
|
artikel
|
| 33 |
Re: John L. Gore, Jonathan L. Wright. Can We Prevent Bladder Cancer Recurrences? Eur Urol 2019;75:602–3
|
Goldstein, Mark R.
|
|
2019
|
75 |
6 |
p. e170
|
artikel
|
| 34 |
Re: Mark Douglas Tyson II, Tatsuki Koyama, Dan Lee, et al. Effect of Prostate Cancer Severity on Functional Outcomes After Localized Treatment: Comparative Effectiveness Analysis of Surgery and Radiation Study Results. Eur Urol 2018;74:26–33
|
Gokce, Ahmet
|
|
2019
|
75 |
6 |
p. e157
|
artikel
|
| 35 |
Re: Maud Rijnders, Astrid A.M. van der Veldt, Tahlita C.M. Zuiverloon, et al. PD-L1 Antibody Comparison in Urothelial Carcinoma. Eur Urol 2019;75:538–40
|
Gevaert, Thomas
|
|
2019
|
75 |
6 |
p. e162-e163
|
artikel
|
| 36 |
Re: Peter K.-F. Chiu, Chi-Fai Ng, Axel Semjonow, et al. A Multicentre Evaluation of the Role of the Prostate Health Index (PHI) in Regions with Differing Prevalence of Prostate Cancer: Adjustment of PHI Reference Ranges is Needed for European and Asian Settings. Eur Urol 2019;75:558–61
|
Heidegger, Isabel
|
|
2019
|
75 |
6 |
p. e158-e159
|
artikel
|
| 37 |
Re: Philip S. Macklin, Mark E. Sullivan, Charles R. Tapping, et al. Tumour Seeding in the Tract of Percutaneous Renal Tumour Biopsy: A Report on Seven Cases from a UK Tertiary Referral Centre. Eur Urol 2019;75:861–7
|
Tran, Maxine G B
|
|
2019
|
75 |
6 |
p. e179-e180
|
artikel
|
| 38 |
Reply to Jae Heon Kim and Benjamin I. Chung's Letter to the Editor re: Teemu J. Murtola, Heimo Syvälä, Teemu Tolonen, et al. Atorvastatin Versus Placebo for Prostate Cancer Before Radical Prostatectomy—A Randomized, Double-blind, Placebo-controlled Clinical Trial. Eur Urol 2018;74:697–701
|
Murtola, Teemu J.
|
|
2019
|
75 |
6 |
p. e166-e167
|
artikel
|
| 39 |
Reply to Luca Boeri and Emanuele Montanari's Letter to the Editor re: Guido Giusti, Silvia Proietti, Moises E. Rodríguez-Socarrás, et al. Simultaneous Bilateral Endoscopic Surgery (SBES) for Patients with Bilateral Upper Tract Urolithiasis: Technique and Outcomes. Eur Urol 2018;74:810–5
|
Giusti, Guido
|
|
2019
|
75 |
6 |
p. e173-e174
|
artikel
|
| 40 |
Reply to Maxine G. Tran, Ravi Barod, and Axel Bex's Letter to the Editor re: Philip S. Macklin, Mark E. Sullivan, Charles R. Tapping, et al. Tumour Seeding in the Tract of Percutaneous Renal Tumour Biopsy: A Report on Seven Cases from a UK Tertiary Referral Centre. Eur Urol 2019;75:861–7
|
Macklin, Philip S.
|
|
2019
|
75 |
6 |
p. e177-e178
|
artikel
|
| 41 |
Reply to Thomas Gevaert, Markus Eckstein, Rodolfo Montironi, and Antonio Lopez-Beltran's Letter to the Editor re: Maud Rijnders, Astrid A.M. van der Veldt, Tahlita C.M. Zuiverloon, et al. PD-L1 Antibody Comparison in Urothelial Carcinoma. Eur Urol 2019;75:538–40
|
Rijnders, Maud
|
|
2019
|
75 |
6 |
p. e160-e161
|
artikel
|
| 42 |
Re: Prostate Cancer-specific Mortality Across Gleason Scores in Black vs Nonblack Men
|
Wallis, Christopher J.D.
|
|
2019
|
75 |
6 |
p. 1036-1037
|
artikel
|
| 43 |
Re: Radical Prostatectomy or Watchful Waiting in Prostate Cancer—29-Year Follow-up
|
Hofer, Luisa
|
|
2019
|
75 |
6 |
p. 1036
|
artikel
|
| 44 |
Re: Rano Matta, Christopher J.D. Wallis, Mitchell G. Goldenberg, et al. Variation and Trends in Antidepressant Prescribing for Men Undergoing Treatment for Nonmetastatic Prostate Cancer: A Population-based Cohort Study. Eur Urol 2019;75:3–7
|
Vale, Salvador
|
|
2019
|
75 |
6 |
p. e168-e169
|
artikel
|
| 45 |
Re: Timu J. Murtola, Hemo Syvälä, Teemu Tolonen, et al. Atorvastatin Versus Placebo for Prostate Cancer Before Radical Prostatectomy—A Randomized, Double-blind, Placebo-controlled Clinical Trial. Eur Urol 2018;74:697–701
|
Kim, Jae Heon
|
|
2019
|
75 |
6 |
p. e164-e165
|
artikel
|
| 46 |
“Ride the Green Light”: Indocyanine Green–marked Off-clamp Robotic Partial Nephrectomy for Totally Endophytic Renal Masses
|
Simone, Giuseppe
|
|
2019
|
75 |
6 |
p. 1008-1014
|
artikel
|
| 47 |
Setting Research Priorities in Partnership with Patients to Provide Patient-centred Urological Cancer Care
|
Rossi, Sabrina H.
|
|
2019
|
75 |
6 |
p. 891-893
|
artikel
|
| 48 |
The Cancer Genome Atlas Expression Subtypes Stratify Response to Checkpoint Inhibition in Advanced Urothelial Cancer and Identify a Subset of Patients with High Survival Probability
|
Kim, Jaegil
|
|
2019
|
75 |
6 |
p. 961-964
|
artikel
|
| 49 |
The ERUS Curriculum for Robot-assisted Partial Nephrectomy: Structure Definition and Pilot Clinical Validation
|
Larcher, Alessandro
|
|
2019
|
75 |
6 |
p. 1023-1031
|
artikel
|
| 50 |
The Platinum Hall of Fame
|
|
|
2019
|
75 |
6 |
p. e147-e154
|
artikel
|
| 51 |
Treatment Outcome, Toxicity, and Predictive Factors for Radioligand Therapy with 177Lu-PSMA-I&T in Metastatic Castration-resistant Prostate Cancer
|
Heck, Matthias M.
|
|
2019
|
75 |
6 |
p. 920-926
|
artikel
|
Tijdschrift beschrijving